Upgrade Alert for Masimo (MASI)
Masimo (NASDAQ:MASI) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $45.75 on volume of 1.5 million shares, above average daily volume of 279,000.
Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.
Potential upside of 0.8% exists for Masimo, based on a current level of $45.75 and analysts' average consensus price target of $46.10. The stock should find initial support at its 50-day moving average (MA) of $40.81 and further support at its 200-day MA of $40.24.
Over the past year, Masimo has traded in a range of $19.30 to $46.00 and closed yesterday at $45.75, 137% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.0% while the 200-day MA has remained constant.
SmarTrend recommended that subscribers consider buying shares of Masimo on February 26th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $39.09. Since that recommendation, shares of Masimo have risen 8.6%. We continue to monitor MASI for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: analyst upgrades/downgrades Masimo